Patents by Inventor Bichun Zhu

Bichun Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenosine receptor activation reagent and the uses of thereof
    Patent number: 10479814
    Abstract: The present invention relates to application of N(6)-(2-hydroxyethyl)-adenosine (HEA) and its derivatives as an adenosine A1 receptor agonist in preparation of drug or food, the HEA and its derivatives are used in treatment of diseases relating to adenosine receptor regulator, such as insomnia, pain, convulsion, apoplexia, Parkinson's disease, opioid drug addiction and kidney ischemia reperfusion injury etc. The present invention provides a new method for treatment of the diseases relating to nervous system and kidney.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: November 19, 2019
    Assignee: Zhejiang Subtropical Crops Research Institute
    Inventors: Yiqiu Chai, Bichun Zhu, Xiuxiu Peng, Yiwei Jin
  • Adenosine receptor activation reagent and the uses of thereof
    Publication number: 20170369520
    Abstract: The present invention relates to application of N(6)-(2-hydroxyethyl)-adenosine (HEA) and its derivatives as an adenosine A1 receptor agonist in preparation of drug or food, the HEA and its derivatives are used in treatment of diseases relating to adenosine receptor regulator, such as insomnia, pain, convulsion, apoplexia, Parkinson's disease, opioid drug addiction and kidney ischemia reperfusion injury etc. The present invention provides a new method for treatment of the diseases relating to nervous system and kidney.
    Type: Application
    Filed: September 11, 2017
    Publication date: December 28, 2017
    Inventors: Yiqiu Chai, Bichun Zhu, Xiuxiu Peng, Yiwei Jin
  • Adenosine receptor activation reagent and the uses of thereof
    Publication number: 20160024135
    Abstract: The present invention relates to application of N(6)-(2-hydroxyethyl)-adenosine (HEA) and its derivatives as an adenosine A1 receptor agonist in preparation of drug or food, the HEA and its derivatives are used in treatment of diseases relating to adenosine receptor regulator, such as insomnia, pain, convulsion, apoplexia, Parkinson's disease, opioid drug addiction and kidney ischemia reperfusion injury etc. The present invention provides a new method for treatment of the diseases relating to nervous system and kidney.
    Type: Application
    Filed: July 22, 2015
    Publication date: January 28, 2016
    Inventors: Yiqiu Chai, Bichun Zhu, Xiuxiu Peng, Yiwei Jin